ProMIS Neurosciences announces collaboration to develop serological test to assess COVID-19 immunity
TORONTO and CAMBRIDGE, Mass., April 15, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company with a unique, core technology to predict novel targets on the ...
STATE LEADERS ARE NOW COMMITTING TO INCREASING COVID-19 SEROLOGY TESTING. KCCI’S CHRIS GOTHNER IS LIVE AT THE STATEHOUSE TO TELL US ABOUT THE STATE’S PLANS AND HOW SEROLOGY TESTING WORKS. CHRIS THIS ...
Testing for COVID-19 continues to be too little too late in the United States. Many groups are working on closing the testing gap, by innovating new tests for both the presence of the virus and ...
A fascinating new preprint discusses the potential for customized serologic testing in individuals who have or have not been vaccinated against the severe acute respiratory syndrome coronavirus 2 ...
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This ...
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Rebecca DuBois, associate professor of ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
CMS set the reimbursement rate for Medicare Administrative Contractors covering the main type of coronavirus antibody test at approximately $42, per an update Tuesday. That rate exceeds investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results